Fig. 3From: Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled studyComparison of incidence of grade ≥ 2 and grade ≥ 3 toxicity between the BMS group and control group. (A-B) Acute HT excluding lymphopenia. (C-D) Leukopenia. (E-F) Neutropenia. Abbreviation HT, hematologic toxicity; BMS, bone marrow sparing; ns, no significance. * P < 0.05 was considered significantBack to article page